Market Leadership InVentiv Health, now part of Syneos Health, operates as a leading integrated biopharmaceutical solutions provider with a strong global presence across more than 110 countries, offering a wide range of clinical and commercial services that cater to the evolving needs of the pharmaceutical industry.

Strategic Mergers The company has recently merged with INC Research in a $4.6 billion deal, consolidating significant market share and creating one of the largest contract research organizations, which presents opportunities for cross-selling and expanding service offerings to a broader client base.

Expanding Capabilities As a fully integrated organization combining CRO and CCO functions, InVentiv Health is well-positioned to support pharmaceutical clients throughout the drug development lifecycle, opening avenues for technology solutions, data analytics, and process optimization services.

Innovation & Growth Having gone public in 2018 and involved in high-profile mergers, the company demonstrates a growth-oriented strategy that values innovation, providing opportunities for sales of advanced analytics, regulatory compliance tools, and digitalization solutions tailored for pharmaceutical R&D and commercialization.

Industry Expansion With a large workforce of over 22,000 employees and a focus on deep therapeutic experience, InVentiv Health is positioned as a trusted partner in life sciences, indicative of potential sales opportunities in specialized medical devices, clinical trial technology, and employee engagement platforms.